Loading clinical trials...
Loading clinical trials...
An Investigation of the Efficacy and Safety of Favipiravir in Hospitalized NON- SEVERE COVID-19 Patients - An Open-label Randomized Controlled Multi Center Trial
Conditions
Interventions
Favipiravir + Standard of Care
Standard of Care
Locations
1
Philippines
Dr. Regina Berba
Manila, National Capital Region, Philippines
Start Date
October 12, 2020
Primary Completion Date
August 31, 2021
Completion Date
August 31, 2021
Last Updated
August 20, 2021
NCT04525716
NCT03188796
NCT06355232
NCT05191420
NCT04611243
NCT04678193
Lead Sponsor
University of the Philippines
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions